头条推荐
sults across all primary and secondary efficacy endpoints, marking a clinical success. The Phase 3 trial in Japan involved 130 patients with moderate to severe knee osteoarthritis (Kellgren–Lawr
r (CEO) of the Japanese subsidiary, reported that they've achieved clear statistical significance across all primary and secondary efficacy endpoints in the Japanese Phase 3 trial.Lee added that the J
当前文章:http://bbcpp.yueduge.cn/m3c/f7se.html
发布时间:00:00:00